Applechat Applechat
Rezultatele cautarii
Vedeti tot
  • Conecteaza-te
    Conecteaza-te
    Inscrie-te
    Căutare
    Night Mode

Căutare

Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni

  • News Feed
  • EXPLORE
  • Pagini
  • Grupuri
  • Events
  • Reels
  • Blogs
  • Offers
  • Jobs
  • Postari
  • Blogs
  • Utilizatori
  • Pagini
  • Grupuri
  • Events
  • Akash Motar a adăugat un sunet Alte
    2026-02-16 15:08:55 -
    PORCN Inhibitor Market Size, Share, Segments and Trend Outlook
    "Market Trends Shaping Executive Summary PORCN Inhibitor Market Size and Share The global PORCN Inhibitor market size was valued at USD 3.39 billion in 2025 and is expected to reach USD 5.40 billion by 2033, at a CAGR of6.00% during the forecast period PORCN Inhibitor Market report performs geographical analysis for the major areas such as North America, China,...
    0 Commentarii 0 Distribuiri 192 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Akash Motar a adăugat un sunet Alte
    2026-01-16 14:22:54 -
    PORCN Inhibitor Market Trends ,Size, Share, Growth Drivers & Future Forecast
    "Global Demand Outlook for Executive Summary PORCN Inhibitor Market Size and Share The global PORCN Inhibitor market size was valued at USD 3.39 billion in 2025 and is expected to reach USD 5.40 billion by 2033, at a CAGR of6.00% during the forecast period In order to make smart decisions about budgeting, Market strategies, product development, and growth...
    0 Commentarii 0 Distribuiri 537 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Akash Motar a adăugat un sunet Alte
    2026-01-19 19:16:51 -
    PORCN Inhibitor Market, Industry Trends, Size, and Forecast to 2033
    PORCN inhibitors are small-molecule drugs targeting the Porcupine (PORCN) enzyme, a key component of the Wnt signaling pathway. The Wnt pathway regulates cell proliferation, differentiation, and survival, and its aberrant activation drives oncogenesis in cancers like colorectal (30–40% Wnt-activated), pancreatic, and breast cancers. PORCN palmitoylates Wnt ligands, enabling their...
    0 Commentarii 0 Distribuiri 491 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
© 2026 Applechat Romaian
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Termeni Confidențialitate Contacteaza-ne Director